Upregulation of lipocortin 1 inhibits tumour necrosis factor‐induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance
Upregulation of lipocortin 1 inhibits tumour necrosis factor‐induced apoptosis in human leukaemic cells: a possible mechanism of resistance to immune surveillance
复制标题
DOI:
10.1111/j.1365-2141.2000.02397.x
复制
发表时间:
2000-12
影响因子:
6.5
通讯作者:
Yu-Ling Wu;Xu‐Rong Jiang;D. Lillington;A. Newland;S. Kelsey
中科院分区:
文献类型:
--
作者:
Yu-Ling Wu;Xu‐Rong Jiang;D. Lillington;A. Newland;S. Kelsey
The signal transduction pathway through which tumour necrosis factor (TNF) induces apoptosis in leukaemic cells may involve activation of cytosolic phospholipase A2 (cPLA2). The steroids dexamethasone (Dex) and 1,25(OH)2 D3 both render U937 leukaemic cells resistant to TNF‐induced apoptosis. In this study, we found that Dex inhibited both spontaneous and TNF‐induced activation of cPLA2. Dex had no direct effect on cellular cPLA2 levels, but facilitated cPLA2 degradation upon subsequent stimulation of cells with TNF. In addition, Dex increased synthesis of the endogenous cPLA2 inhibitor lipocortin 1 (LC1). An antisense oligonucleotide to LC1 could completely abrogate Dex‐induced resistance to the cytotoxic action of TNF. Constitutive LC1 levels were relatively higher in myeloid leukaemic blasts showing resistance to TNF than TNF‐sensitive myeloid leukaemic cell lines. Our data suggest that Dex confers the resistance of U937 cells to TNF‐induced apoptosis by upregulating intracellular levels of LC1 and by facilitating a negative‐feedback loop, which is activated upon stimulation with TNF. High constitutive levels of LC1 in leukaemic blasts may protect them against immune‐mediated killing.